Cayman Chemical SynthetIc LIncomycIn 25mg
A lincosamide antibiotic; active against S. aureus, S. epidermidis, S. pneumoniae, and S. pyogenes (MICs = 0.2-3.2, 0.4-1.8, 0.01-0.8, and 0.04-0.8 UG/ml, respectively); selectively inhibits protein synthesis in purified ribosomes from S. aureus over E. coli (IC50s = 0.03 and 1.7 UG/ml, respectively, in cell-free assays); protective against development of mastitis in an S. aureus-induced mouse model of acute mastitis (PD50 = 3.5 mg/kg)